Advertisement

Ads Placeholder
Loading...

Moderna, Inc.

MRNA•NASDAQ
Healthcare
Biotechnology
$49.20
$-0.83(-1.66%)
U.S. Market opens in 19h 18m

Moderna, Inc. (MRNA) Stock Overview

Explore Moderna, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.4B
P/E Ratio-6.83
EPS (TTM)$-7.26
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$51.89
3 Months$50.62
1 Year Target$54.96

MRNA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Moderna, Inc. (MRNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $54.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.83 and a market capitalization of 19.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.66%
5-Day Change
-7.67%
1-Month Change
-1.26%
3-Month Change
59.43%
6-Month Change
72.69%
Year-to-Date (YTD) Change
59.43%
1-Year Change
91.22%
3-Year Change
-69.15%
5-Year Change
-62.13%
All-Time (Max) Change
164.52%

Contact Information

https://www.modernatx.com
617 714 6500
325 Binney Street, Cambridge, MA, 02142

Company Facts

58,000 Employees
IPO DateDec 7, 2018
CountryUS
Actively Trading

Frequently Asked Questions